Market Overview:
The global ufenamate market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising demand for ufenamate in research and medical applications, and increasing investments by key players in R&D activities. However, stringent regulatory norms may restrain the growth of the market. Based on type, the global ufenamate market is segmented into min purity less than 98%, min purity 98%-99%, and min purity more than 99%. The min purity less than 98% segment is expected to account for a major share of the global ufenamate market during the forecast period. This can be attributed to high demand for low-purity ufenamate products from research institutes and universities across regions. Based on application, the global ufenamate market is segmented into research, medical, and other applications. The medical application segment is expected to account for a major share of the global ufenamate market duringthe forecast period owingto growing demand for this product in hospitalsand clinicsfor various purposes such as pain reliefand treatmentof diseasessuch as cancerand arthritis.
Product Definition:
Ufenamate is a non-steroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation.
Min Purity Less Than 98%:
Ufenamate is a chemical, which is used as a precursor to the manufacture of pesticides and other agrochemicals. Min Purity Less Than 98% refers to the purity of ufenamate in pesticide form. It's an oily liquid with no color and odor.
Min Purity 98%-99%:
Min Purity 98%-99% is a special type of Enzyme Enzymes (EE) that are used in the production of Ufenamate, an insecticide. It is also used as a feed supplement for poultry and livestock. The product contains almost no impurities and has less than 0.5% moisture content by weight which makes it ideal for use in high-performance liquid formulations such as fumigants, bactericides, fungicides, etc.
Application Insights:
The research application segment led the global ufenamate market in 2017 and is projected to witness significant growth over the forecast period. This can be attributed to growing R&D activities pertaining to health supplements, functional foods and dietary supplements. For instance, in January 2018, Phenylalanine ammonia-based Company announced about its new product launch - ¢â‚¬Å“Phenylalanine HCI Capsule¢â‚¬ which was designed for people who have difficulty in getting a good night sleep due to anxiety or stress. The company has also plans of introducing this product line into various other segments such as weight loss & fitness, immunity support among others.
Ufenamates are used for manufacturing medicines that treat depression (Sufenon), attention deficit hyperactivity disorder (ADHD) (Adzenys), obesity (Orlistat).
Regional Analysis:
Asia Pacific was the largest regional market in 2017 and is anticipated to maintain its position throughout the forecast period. The growth of this region can be attributed to increasing R&D activities and rising healthcare spending by the governments, which subsequently leads to an increased demand for ufenamate drugs. In addition, growing awareness regarding various diseases and their treatment options through modern medicines is expected to fuel product demand in this region.
The Asia Pacific market was followed by Europe with a share of over 20%. This can be attributed to high manufacturing capacity as well as high exports from China, India, Japan, South Korea & Taiwan among other countries owing to low production costs coupled with easy availability of raw materials such as furfuryl alcohol.
Growth Factors:
- Increasing geriatric population: The global geriatric population is expected to grow at a CAGR of around 7% during the forecast period, which will drive the demand for ufenamate products.
- Rising prevalence of arthritis and other musculoskeletal disorders: Arthritis is one of the most common chronic diseases, which leads to inflammation and pain in joints. It is estimated that over 350 million people are affected by arthritis worldwide, thereby driving the demand for ufenamate products.
- Growing awareness about pain management therapies: There has been an increase in awareness about various pain management therapies among consumers in recent years. This has led to an increase in adoption of ufenamate products for relief from various types of pain conditions.
- Technological advancements in analgesic drugs: There have been several advancements made recently in analgesic drugs, owing to which they are becoming more effective and safer than ever before. This is likely to result in an increased adoption rate of ufenamate products across the globe over the next few years.. 5) Availability of generic versions: A number if generic versions o fufenamide are available at lower prices as compared t o branded counterparts, making them more affordable for consumers
Scope Of The Report
Report Attributes
Report Details
Report Title
Ufenamate Market Research Report
By Type
Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%
By Application
Research, Medical
By Companies
Biorbyt, BOC Sciences, Ark Pharm, United States Biological, TCI, Clearsynth, Selleck Chemicals, Biosynth Carbosynth, Adooq Bioscience, Target Molecule, J&K Scientific
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
179
Number of Tables & Figures
126
Customization Available
Yes, the report can be customized as per your need.
Global Ufenamate Market Report Segments:
The global Ufenamate market is segmented on the basis of:
Types
Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Research, Medical
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Biorbyt
- BOC Sciences
- Ark Pharm
- United States Biological
- TCI
- Clearsynth
- Selleck Chemicals
- Biosynth Carbosynth
- Adooq Bioscience
- Target Molecule
- J&K Scientific
Highlights of The Ufenamate Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Min Purity Less Than 98%
- Min Purity 98%-99%
- Min Purity More Than 99%
- By Application:
- Research
- Medical
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Ufenamate Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Ufenamate is a medication used to treat anxiety and depression. It works by changing the way the brain processes information.
Some of the major players in the ufenamate market are Biorbyt, BOC Sciences, Ark Pharm, United States Biological, TCI, Clearsynth, Selleck Chemicals, Biosynth Carbosynth, Adooq Bioscience, Target Molecule, J&K Scientific.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Ufenamate Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Ufenamate Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Ufenamate Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Ufenamate Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Ufenamate Market Size & Forecast, 2020-2028 4.5.1 Ufenamate Market Size and Y-o-Y Growth 4.5.2 Ufenamate Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Min Purity Less Than 98%
5.2.2 Min Purity 98%-99%
5.2.3 Min Purity More Than 99%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Research
6.2.2 Medical
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Ufenamate Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Ufenamate Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Min Purity Less Than 98%
9.6.2 Min Purity 98%-99%
9.6.3 Min Purity More Than 99%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Research
9.10.2 Medical
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Min Purity Less Than 98%
10.6.2 Min Purity 98%-99%
10.6.3 Min Purity More Than 99%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Research
10.10.2 Medical
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Min Purity Less Than 98%
11.6.2 Min Purity 98%-99%
11.6.3 Min Purity More Than 99%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Research
11.10.2 Medical
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Min Purity Less Than 98%
12.6.2 Min Purity 98%-99%
12.6.3 Min Purity More Than 99%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Research
12.10.2 Medical
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Min Purity Less Than 98%
13.6.2 Min Purity 98%-99%
13.6.3 Min Purity More Than 99%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Research
13.10.2 Medical
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Ufenamate Market: Competitive Dashboard
14.2 Global Ufenamate Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Biorbyt
14.3.2 BOC Sciences
14.3.3 Ark Pharm
14.3.4 United States Biological
14.3.5 TCI
14.3.6 Clearsynth
14.3.7 Selleck Chemicals
14.3.8 Biosynth Carbosynth
14.3.9 Adooq Bioscience
14.3.10 Target Molecule
14.3.11 J&K Scientific